期刊文献+

Lyn酶在非酒精性脂肪性肝炎组织Kupffer细胞中的表达及意义 被引量:2

原文传递
导出
摘要 目的分析非酒精性脂肪性肝炎(NASH)组织Kupffer细胞中Lyn酶的表达及其临床意义。方法收集37例手术切除的肝组织石蜡标本,其中12例原发性肝癌癌旁正常肝组织,25例炎症反应明显的NASH组织。利用免疫组化法检测肝组织Kupffer细胞中Lyn酶的表达情况,并分析其阳性率与肝组织炎症的相关性。结果 25例NASH患者Lyn酶阳性表达25例,其中染色强度以上的23例(92%),Lyn阳性率与NASH的炎症程度呈正相关(P<0.05)。结论 Lyn的异常表达与肝脏炎症程度显著相关,检测其表达有助于NASH炎症程度的评价。
出处 《江苏医药》 CAS 北大核心 2014年第21期2608-2610,F0002,共4页 Jiangsu Medical Journal
基金 江苏省自然科学基金(SBK2011394) 南通市社会发展计划项目(K11907 HS2013054)
  • 相关文献

参考文献12

  • 1Abram CL,Lowell CA.The diverse functions of Src family kinases in macrophages[J].Front Biosci,2008,13:4426-4450.
  • 2Okutani D,Lodyga M,Han B,et al.Src protein tyrosine kinase family and acute inflammatory responses[J].Am J Physiol Lung Cell Mol Physiol,2006,291(2):129-141.
  • 3Odegaard JI,Ricardo-Gonzalez RR,Red Eagle A,et al.Alternative M2activation of Kupffer cells by PP-AR delta ameliorates obesity-induced insulin resistance[J].Cell Metab,2008,7(6):496-507.
  • 4Ikura Y,Ohsawa M,Suekane T,et al.Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease:impact on disease progression[J].Hepatology,2006,43(3):506-514.
  • 5Kim MS,Sweeney TR,Shigenaga JK,et al.Tumor necrosis factor and interleukin 1 decrease RXRalpha,PPARal-pha,PPARgamma,LXRalpha,and the coactivators SRC-1,PGC-1alpha,and PGC-1beta in liver cells[J].Metabolism,2007,56(2):267-279.
  • 6Stienstra R,Saudale F,Duval C,et al.Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity[J].Hepatology,2010,51(2):511-522.
  • 7Harte AL,da Silva NF,Creely SJ,et al.Elevated endotoxin levels in non-alcoholic fatty liver disease[J].J Inflamm(Lond),2010,7:15.
  • 8Ingley E.Src family kinases:regulation of their activities,levels and identification of new pathways[J].Biochim Biophys Acta,2008,1784(1):56-65.
  • 9Okutani D.Src protein tyrosine kinase family and acute lung injury[J].Nihon Rinsho Meneki Gakkai Kaishi,2006,29(5):334-341.
  • 10Xiao W,Hong H,Kawakami Y,et al.Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck,SHIP,and Stat5[J].J Clin Invest,2008,118(3):924-934.

同被引文献50

  • 1钱晓武,范竹萍,邱德凯.脂联素及受体与非酒精性脂肪性肝炎[J].国际消化病杂志,2006,26(3):157-160. 被引量:2
  • 2Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling [ J ]. Cell, 1995,80 ( 2 ) : 225 - 236.
  • 3Dengjel J, I Kratchmarova, and B Blagoev. Receptor tyrosine kinase signaling: a view from quantitative proteomics [ J ]. Mol Biosyst, 2009,5(10) :1112 -1121.
  • 4Kris MG, RB Natale, RS Herbst, et al. Efficacy of gefitinib, an in- hibitor of the epidermal growth factor receptortyrosine kinase, in symptomatic patients with non - small cell lung cancer: a random- ized trial[ J ]. JAMA ,2003,290 ( 16 ) :2149 - 2158.
  • 5Chen Q, z Zhou, L Shah, et al. The importance of Src signaling in sarcoma [ J ]. Oncol Lett,2015,10 ( 1 ) : 17 - 22.
  • 6Umemori H, A Wanaka, H Kato, et al. Specific expressions of Fyn and Lyn, lymphcyte antigen receptor - associated tyrosine kinases, in the central nervous system[ J ]. Brain Res Mol Brain Res, 1992, 16(3 -4) :303 -310.
  • 7Abram CL and CA Lowell. The diverse functions of Src family kina- ses in maerophages[ J]. Front Biosei,2008,13:4426 - 4450.
  • 8Sanjuan MA, N Rao, KT Lai, et al. CpG - induced tyrosine phos- phorylation occurs via a TLR9 - independent mechanism and is re- quired for cytokine secretion [ J ]. J Mol Biol,2006,172 ( 7 ) : 1057 - 1068.
  • 9Hibbs ML and KW Harder. The duplicitous nature of the Lyn tyro- sine kinase in growth factor signaling[ J]. Growth Factors ,2006,24 (2) :137 -149.
  • 10Tabaries S, MG Annis, BE Hsu, et al. Claudin - 2 expression and is a therapeutic target for breast cancer liver metastasis [ J ]. Onco- target,2015,6( 11 ) :9476 -9987.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部